LAIR1 and adenocarcinoma: To also investigate a potentially prognostic significance, we assessed the association of LAIR-1 expression with survival in the whole NSCLC discovery cohort (i.e., LUAD + LUSC+ other), as well as individually in adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) patient subgroups.